Company intelligence / Profile preview

TKTX

Not explicitly listed; likely China-based manufacturer with global distribution via e-commerce platforms.[7]
Ownership
Private
Development stage
Commercial
01

Overview

TKTX produces topical numbing creams and gels primarily for use in cosmetic procedures to reduce pain. Their products contain high concentrations of anesthetic agents like lidocaine. The FDA has issued a warning letter to the company regarding unapproved drug status and safety concerns due to excessive lidocaine content exceeding over-the-counter limits; these products may pose health risks if misused or applied on large/broken skin areas

Therapeutic areas
Dermatology
Modalities
Topical anesthetics (creams, gels, sprays) containing lidocaine and related agents
Industry
Biotech
02

Drug pipeline

4 assets

agalsidase alfa

Commercial
Indications
Fabry disease

3 more assets in the full pipeline.

Request access →
03

Partnerships

No major pharmaceutical or biotech partnerships reported; operates mainly as an independent consumer health brand.

Beyond the preview

Go deeper on TKTX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TKTX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call